30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
The government and market response to the COVID-19 pandemic is presenting novel and difficult legal ...
Read More >
PepsiCo, Inc. (Pepsi) is the sponsor of a defined benefit pension plan. Like several other prominent...
Read More >
On October 10, 2019, California Governor Gavin Newsom signed into law Assembly Bill 51 (AB 51) prohi...
Read More >
In the context of an M&A transaction, practitioners are routinely left to navigate the various stand...
Read More >
Title VII, which prohibits employment discrimination on the basis of race, color, religion, sex, and...
Read More >
Q: Is FMLA 480 hours under every circumstance? A: No, the FMLA uses something called the fluctuatin...
Read More >